J. Miller

Efficacy of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: 36-month results of the ZO-FAST Study

Holger Eidtmann, Richard de Boer, Nigel Bundred et al. · Annals of Oncology · 2010 · 280 citations

Medicine, Oncology, Pharmacotherapy +15

Effective inhibition of aromatase inhibitor‐associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole

Nigel Bundred, Ian Campbell, Neville Davidson et al. · Cancer · 2008 · 217 citations

Medicine, Oncology, Pharmacotherapy +17

Cardiac-Myocyte-Specific Excision of the Vinculin Gene Disrupts Cellular Junctions, Causing Sudden Death or Dilated Cardiomyopathy

Alice E. Zemljic‐Harpf, J. Miller, Scott A. Henderson et al. · Molecular and Cellular Biology · 2007 · 212 citations · Full text

Life Sciences, Cardiology, Cell Biology +15

Immediate Administration of Zoledronic Acid Reduces Aromatase Inhibitor–Associated Bone Loss in Postmenopausal Women With Early Breast Cancer: 12-Month Analysis of the E-ZO-FAST Trial

Antonio Llombart‐Cussac, Antonio Frassoldati, Outi Paija et al. · Clinical Breast Cancer · 2011 · 131 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Impact of Zoledronic Acid in Postmenopausal Women with Early Breast Cancer Receiving Adjuvant Letrozole: Z-FAST, ZO-FAST, and E-ZO-FAST.

Robert E. Coleman, N.J. Bundred, Richard de Boer et al. · Cancer Research · 2009 · 63 citations

Medicine, Oncology, Pharmacology +17